The effect of perceived psychological stress on the immunogenicity of the quadrivalent human papillomavirus vaccine in males
Background: The human papillomavirus (HPV) vaccine is recommended for male and female recipients aged 9–26 years, and is effective in preventing HPV infection and cancer precursors. However, there is variability in immunogenicity among recipients as measured by anti-HPV geometric mean titers. In thi...
Main Authors: | Rebecca F. Wu, Richard K. Zimmerman, Chyongchiou Jeng Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-03-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2016.1236880 |
Similar Items
-
Human Papillomavirus Vaccines: An Updated Review
by: Liqin Cheng, et al.
Published: (2020-07-01) -
Human papillomavirus (HPV) infection and vaccination: A cross-sectional study of college students’ knowledge, awareness, and attitudes in Villanova, PA
by: Jennifer A. Goldfarb, et al.
Published: (2022-04-01) -
Ongoing challenges and future directions of human papillomavirus vaccination
by: O. S. Alyautdina, et al.
Published: (2020-09-01) -
Exploration of the effect of human papillomavirus (HPV) vaccination in a cohort of pregnant women in Montreal, 2010–2016
by: El Hadji Malick Sarr, et al.
Published: (2019-08-01) -
A brief information–motivation–behavioral skills intervention to promote human papillomavirus vaccination among college-aged women
by: Perez GK, et al.
Published: (2016-10-01)